Home › Researcher directory › Barry E. Rosenbloom

Barry E. Rosenbloom

Affiliation : Cedars-Sinai Medical Center

• 2Publications (affiliation in the United States)
• 80Total publications
• 4661Citations
• 29h-index

ORCIDOpenAlex

Research profile

Barry E. Rosenbloom has 2 indexed publications (2018–2019). Their work appears in “Blood Cells Molecules and Diseases”. Their most cited article, “Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1” (2018), has been cited 29 times. Their work is co-authored with at least 5 researchers.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

• Lysosomal Storage Disorders Research
• Glycogen Storage Diseases and Myoclonus
• Metabolism and Genetic Disorders
• Lymphoma Diagnosis and Treatment
• Multiple Myeloma Research and Treatments

Publications (2)

• Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
  2019 · Blood Cells Molecules and Diseases · cited 2 times
• Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
  2018 · Blood Cells Molecules and Diseases · cited 29 times

Publications per year

• 20191
• 20181

Collaborations

Partner institutions : New York University · Icahn School of Medicine at Mount Sinai · Duke University · Yale University · Northwestern University

Co-authors

• Joel Charrow
• Pramod Kumar Mistry
• Priya Sunil Kishnani
• Manisha Balwani
• Gregory M. Pastores

Bibliographic data from OpenAlex (open database).